Neil William Aubuchon insider trades

Open-market stock purchases and sales by Neil William Aubuchon, Chief Commercial Officer at Viking Therapeutics, Inc, from SEC Form 4 filings since Jan 12, 2026.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -23%.

Recent trades

DateStockTradeValue
Mar 10, 2026VKTX Viking Therapeutics, IncBought$150K
Jan 12, 2026VKTX Viking Therapeutics, IncBought (not open market)—

Companies traded

  • VKTX Viking Therapeutics, Inc: 1 buy, last Mar 10, 2026

Get free alerts when Neil William Aubuchon files a new trade →